Piobakteriofag integrated liquid has the ability to specifically lyse bacteria staphylococci, streptococci, enterococci, Proteus, Klebsiella pneumonia and oksitoka, durabolin injection aeruginosa and Escherichia coli.
Treatment and prevention of inflammatory and intestinal diseases caused by staphylococci, enterococci, streptococci, Pseudomonas aeruginosa, Klebsiella, pathogenic E. coli serogroups different, Proteus at home, rectal and external use.
Indications for use:
diseases of the ear, nose, throat, respiratory tract and lungs – inflammation of the sinuses, middle ear, tonsillitis, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleurisy; surgical infections – festering wounds, burns, abscesses, cellulitis, boils, carbuncles, gidroadenit, whitlow, abscess, mastitis, bursitis, osteomyelitis; – Urogenital infections – urethritis, cystitis, pyelonephritis, coleitis, endometritis, salpingo; post-traumatic conjunctivitis, keratoconjunctivitis, corneal ulcers and purulent iridocyclitis.
Instructions Instead approved of 22.05.03
- enteric infections – gastroenterocolitis, cholecystitis, dysbiosis;
- generalized septic diseases;
- pyo-inflammatory diseases of the newborn – ofmalit, pyoderma, conjunctivitis, gastroenterocolitis, sepsis, and others;
- Other diseases caused durabolin injection by bacteria staphylococci, streptococci, enterococci, Proteus, Klebsiella pneumonia and oksitoka, Pseudomonas aeruginosa and Escherichia coli.
From prevention to drug is used for treatment of operational and svezheinfitsirovannyh wounds, as well as for the prevention of nosocomial infections on epidemic indications.
An important condition for effective phage therapy is fagochuvstvitelnosti preliminary identification of the pathogen.
Dosage and Administration
Treatment of inflammatory diseases with localized lesions should be carried out simultaneously both topically and orally, 7-20 days (if clinically indicated).
Depending on the nature of the infection bacteriophage is used:
1. Topically in the form of irrigation, lotions and phage plugging liquid in an amount up to 200 ml depending on the size of the affected area. When introduced into the bacteriophage abscess cavity after removal of pus hearth by puncture. The amount of the drug must be somewhat smaller than the volume of remote pus.When osteomyelitis after appropriate surgical treatment of the wound poured bacteriophage 10-20 ml.
2. Introduction to the cavity – pleural, joint and other confined to cavity 100 mL bacteriophage then allowed capillary drainage through which several days reintroduced bacteriophage.
3. If cystitis, pyelonephritis, urethritis the drug is taken orally. If the cavity of the bladder or the renal pelvis drained, bacteriophage introduced through tsistostomu nephrostomy or 1-2 times a day for 20-50 ml into the bladder and 7.5 ml of the renal pelvis.
4. In chronic inflammatory gynecological diseases, the drug is administered into the cavity of the vagina, the uterus at a dose of 5-10 ml once daily.
5. In chronic inflammatory diseases of the ear, nose and throat drug is administered at a dose of 2-10 ml 1-3 times a day. The bacteriophage is used for rinsing, washing, landfill, introducing the wetted turundas (leaving them for 1 hour).
6. When conjunctivitis and keratoconjunctivites drug instilled 2-3 drops 4-5 times a day, with purulent corneal ulcer – 4-5 drops in purulent iridotsiklitah durabolin injection drug use 6-8 drops every 3 hours in combination with oral route.
7. In the treatment of stomatitis, periodontitis and chronic generalized preparation is used as a rinse oral 3-4 times a day at a dose of 10-20 ml, and introduced into periodontal pockets turundas piobakteriofagom soaked for 5-10 minutes.
8. When intestinal forms of the disease, internal diseases, dysbacteriosis bacteriophage used through the mouth and an enema. Oral bacteriophage given 3 times a day on an empty stomach 1 hour before meals. In the form of enemas administered 1 time per day instead of a single oral administration.